Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Said

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1998
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX miceE Elstner, C Müller, K Koshizuka, et al.
British Journal of Cancer|September 5, 2013
PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cellsW Chien, K L Lee, L W Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expressionY E Whang, X Wu, H Suzuki, et al.
Oncogene|March 14, 2000
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancerZ Gu, G Thomas, J Yamashiro, et al.
Oncogene|May 15, 2012
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiformeD Yin, S Ogawa, N Kawamata, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 1999
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphomaD Widney, G Gundapp, J W Said, et al.
The Journal of Urology|July 4, 2001
Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcomeA Zisman, A J Pantuck, D Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Improved prognostication of renal cell carcinoma using an integrated staging systemA Zisman, A J Pantuck, F Dorey, et al.
Oncogenesis|May 22, 2013
Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survivalD H Lee, S Amanat, C Goff, et al.
Science (New York, N.Y.)|June 20, 1997
Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patientsM B Rettig, H J Ma, R A Vescio, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1998
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX miceE Elstner, C Müller, K Koshizuka, et al.
British Journal of Cancer|September 5, 2013
PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cellsW Chien, K L Lee, L W Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expressionY E Whang, X Wu, H Suzuki, et al.
Oncogene|March 14, 2000
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancerZ Gu, G Thomas, J Yamashiro, et al.
Oncogene|May 15, 2012
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiformeD Yin, S Ogawa, N Kawamata, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 1999
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphomaD Widney, G Gundapp, J W Said, et al.
The Journal of Urology|July 4, 2001
Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcomeA Zisman, A J Pantuck, D Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Improved prognostication of renal cell carcinoma using an integrated staging systemA Zisman, A J Pantuck, F Dorey, et al.
Oncogenesis|May 22, 2013
Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survivalD H Lee, S Amanat, C Goff, et al.
Science (New York, N.Y.)|June 20, 1997
Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patientsM B Rettig, H J Ma, R A Vescio, et al.
Pageof 14